St Jude quits AdvaMed after tax dispute
This article was originally published in Clinica
St Jude Medical has withdrawn its membership from AdvaMed , the biggest medical device trade industry association in the US, after the firm disagreed with the latter's stance on the forthcoming tax proposal from the US government. The dispute arose between the two parties over AdvaMed’s view that taxes should be paid based on product complexity. St Jude itself manufactures high-tech implanted devices such defibrillators and implants, which are given a class III notification by the FDA as they generate greater revenues than disposable or low-tech products.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals